1. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
    Rui Liu et al, 2015, European Journal of Pharmacology CrossRef
  2. Structure–Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors
    Hirari Yamahana et al, 2021, Chemical and Pharmaceutical Bulletin CrossRef
  3. To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking
    Junli Zhang et al, 2023, Frontiers in Pharmacology CrossRef
  4. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer
    Lixia Huang et al, 2022, Current Pharmaceutical Design CrossRef
  5. BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
    S. Elizabeth Franks et al, 2016, BMC Research Notes CrossRef
  6. Circ_0014130 Participates in the Proliferation and Apoptosis of Nonsmall Cell Lung Cancer Cells via the miR-142-5p/IGF-1 Axis
    Mengjie Wang et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  7. Pulmonary Delivery of Docetaxel and Celecoxib by PLGA Porous Microparticles for Their Synergistic Effects Against Lung Cancer
    Jaber Emami et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef